Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic strategies for this aggressive disease.
Matthew Oser, MD
Advertisement
Matthew Oser, MD, is an associate professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School.
Articles by Matthew Oser, MD
Advertisement
Latest Updated Articles
New Targets Emerge for Aggressive Small Cell Lung CancerPublished: September 16th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
